Compounds > carbidopa

carbidopa and Neuroleptic Malignant Syndrome

carbidopa has been researched along with Neuroleptic Malignant Syndrome in 18 studies

Research

Studies (18)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (22.22)	18.7374
1990's	7 (38.89)	18.2507
2000's	5 (27.78)	29.6817
2010's	2 (11.11)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bonnici, A; Hornstein, D; Ruiner, CE; St-Laurent, L	1
Birthi, P; McDowell, S; Perry, D; Salles, S	1
Reingardiene, D	1
Hillis, RE; Lee, DA	1
Herkes, GK; McKay, D; Meagher, LJ; Needham, M	1
Kuno, S; Mizuta, E; Nakatake, M; Yamasaki, S	1
Abraham, OC; Archana, S; Cherian, AM; Kurien, T; Rajeev, KK	1
Cernek, PK; Shoop, SA	1
Egi, N; Harada, T; Kumagai, R; Kurokawa, K; Nakamura, S; Okazaki, M; Shimote, K	1
Bonoma, RA; Iwuagwu, CU; Riley, D	1
Susman, VL	1
Lefeber, EJ; Rainer, C; Scheinost, NA	1
Altus, P; Hencey, MA; Weissman, MS	1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T	1
Munitz, H; Shalev, A	1
Harris, M; Nora, L; Tanner, CM	1
Lazarus, A	1
Di Battista, G; Di Meo, L; Figà-Talamanca, L; Gualandi, C; Lo Russo, F; Neri, G	1

Reviews

4 review(s) available for carbidopa and Neuroleptic Malignant Syndrome

Article	Year
[Neuroleptic malignant syndrome]. Medicina (Kaunas, Lithuania), 2002, Volume: 38, Issue:1 Topics: Acute Kidney Injury; Adult; Amantadine; Bromocriptine; Carbidopa; Contraindications; Dantrolene; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Female; Humans; Intensive Care Units; Levodopa; Male; Muscle Relaxants, Central; Neuroleptic Malignant Syndrome; Prognosis; Rhabdomyolysis	2002
Clinical management of neuroleptic malignant syndrome. The Psychiatric quarterly, 2001,Winter, Volume: 72, Issue:4 Topics: Bromocriptine; Carbidopa; Dopamine Agonists; Drug Combinations; Electroconvulsive Therapy; Guidelines as Topic; Humans; Levodopa; Neuroleptic Malignant Syndrome; Physical Therapy Specialty	2001
Neuroleptic malignant syndrome. When levodopa withdrawal is the cause. Postgraduate medicine, 1991, Volume: 89, Issue:5 Topics: Aged; Carbidopa; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome	1991
The neuroleptic malignant syndrome: agent and host interaction. Acta psychiatrica Scandinavica, 1986, Volume: 73, Issue:4 Topics: Adolescent; Adult; Aftercare; Aged; Akathisia, Drug-Induced; Amantadine; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Bromocriptine; Carbidopa; Child; Child, Preschool; Dantrolene; Dose-Response Relationship, Drug; Electroconvulsive Therapy; Female; Haloperidol; Humans; Leukocytosis; Male; Middle Aged; Neuroleptic Malignant Syndrome	1986

Other Studies

14 other study(ies) available for carbidopa and Neuroleptic Malignant Syndrome

Article	Year
An interaction between levodopa and enteral nutrition resulting in neuroleptic malignant-like syndrome and prolonged ICU stay. The Annals of pharmacotherapy, 2010, Volume: 44, Issue:9 Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Enteral Nutrition; Food-Drug Interactions; Humans; Intensive Care Units; Length of Stay; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease	2010
Neuroleptic malignant syndrome associated with the use of carbidopa/levodopa for dystonia in persons with cerebral palsy. PM & R : the journal of injury, function, and rehabilitation, 2012, Volume: 4, Issue:5 Topics: Carbidopa; Cerebral Palsy; Child; Dopamine Agents; Drug Therapy, Combination; Dystonia; Follow-Up Studies; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome	2012
Viral encephalitis complicated by neuroleptic malignant syndrome in a 7-year-old girl. Pediatric emergency care, 2003, Volume: 19, Issue:2 Topics: Anticonvulsants; Carbidopa; Child; Dopamine Agents; Drug Therapy, Combination; Encephalitis, Viral; Epilepsy, Tonic-Clonic; Female; Haloperidol; Humans; Hypnotics and Sedatives; Levodopa; Neuroleptic Malignant Syndrome; Psychomotor Agitation	2003
Parkinsonism-hyperpyrexia syndrome: the role of electroconvulsive therapy. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2006, Volume: 13, Issue:8 Topics: Acetaminophen; Acyclovir; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiparkinson Agents; Antiviral Agents; Anxiety; Carbidopa; Ceftriaxone; Cervical Vertebrae; Depression; Dexamethasone; Diazepam; Doxepin; Electroconvulsive Therapy; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Oxycodone; Pain; Parkinson Disease; Selegiline; Spinal Injuries	2006
Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period. Neurology, 1993, Volume: 43, Issue:5 Topics: Body Temperature; Carbidopa; Drug Combinations; Female; Humans; Levodopa; Menstrual Cycle; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease	1993
Management of neuroleptic malignant syndrome--a series of eight cases. The Journal of the Association of Physicians of India, 1993, Volume: 41, Issue:2 Topics: Adolescent; Adult; Bromocriptine; Carbidopa; Dantrolene; Dopamine Agents; Drug Combinations; Female; Humans; India; Levodopa; Male; Muscular Diseases; Neuroleptic Malignant Syndrome	1993
Carbidopa/levodopa in the treatment of neuroleptic malignant syndrome. The Annals of pharmacotherapy, 1997, Volume: 31, Issue:1 Topics: Adult; Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome	1997
[A case of impending neuroleptic malignant syndrome associated with Shy-Drager syndrome]. No to shinkei = Brain and nerve, 1998, Volume: 50, Issue:8 Topics: Antiparkinson Agents; Carbidopa; Drug Therapy, Combination; Fludrocortisone; Humans; Levodopa; Male; Middle Aged; Neuroleptic Malignant Syndrome; Shy-Drager Syndrome	1998
Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a-catechol-o-methyl transferase inhibitor. The American journal of medicine, 2000, Apr-15, Volume: 108, Issue:6 Topics: Aged; Aged, 80 and over; Akathisia, Drug-Induced; Antiparkinson Agents; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Confusion; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Nitrophenols; Substance Withdrawal Syndrome; Tolcapone	2000
A 73-year-old woman with confusion, rigidity, and fever. Hospital practice (Office ed.), 1991, Jun-15, Volume: 26, Issue:6 Topics: Aged; Carbidopa; Confusion; Drug Therapy, Combination; Female; Fever; Humans; Levodopa; Muscle Rigidity; Neuroleptic Malignant Syndrome; Parkinson Disease	1991
Neuroleptic malignant syndrome without neuroleptics. Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan	1990
Neuroleptic malignant syndrome responsive to carbidopa/levodopa: support for a dopaminergic pathogenesis. Clinical neuropharmacology, 1987, Volume: 10, Issue:2 Topics: Adult; Carbidopa; Drug Combinations; Haloperidol; Humans; Levodopa; Male; Neuroleptic Malignant Syndrome; Psychotic Disorders	1987
Therapy of neuroleptic malignant syndrome. Psychiatric developments, 1986,Spring, Volume: 4, Issue:1 Topics: Amantadine; Bromocriptine; Carbidopa; Combined Modality Therapy; Dantrolene; Diazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroconvulsive Therapy; Humans; Levodopa; Neuroleptic Malignant Syndrome; Receptors, Dopamine	1986
Hyperthermia after discontinuance of levodopa and bromocriptine therapy: impaired dopamine receptors a possible cause. Neurology, 1985, Volume: 35, Issue:2 Topics: Body Temperature Regulation; Bromocriptine; Carbidopa; Drug Combinations; Female; Fever; Humans; Levodopa; Malignant Hyperthermia; Middle Aged; Neuroleptic Malignant Syndrome; Parkinson Disease; Receptors, Dopamine	1985